Citadel Advisors
MPT

Citadel Advisors’s Medical Properties Trust MPT Stock Holding History

Citadel Advisors’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.84M Sell
829,200
-408,000
-33% -$2.13M ﹤0.01% 4791
2025
Q4 		$6.19M Sell
1,237,200
-217,500
-15% -$1.13M ﹤0.01% 3954
2025
Q3 		$7.38M Sell
1,454,700
-300,300
-17% -$1.32M ﹤0.01% 3715
2025
Q2 		$7.56M Buy
1,755,000
+186,800
+12% +$923K ﹤0.01% 3436
2025
Q1 		$9.46M Buy
1,568,200
+88,200
+6% +$446K ﹤0.01% 2932
2024
Q4 		$5.85M Buy
1,480,000
+396,400
+37% +$1.78M ﹤0.01% 3711
2024
Q3 		$6.34M Buy
1,083,600
+71,900
+7% +$354K ﹤0.01% 3566
2024
Q2 		$4.36M Sell
1,011,700
-924,200
-48% -$4.43M ﹤0.01% 3964
2024
Q1 		$9.1M Buy
1,935,900
+227,000
+13% +$869K ﹤0.01% 3061
2023
Q4 		$8.39M Sell
1,708,900
-1,959,300
-53% -$9.59M ﹤0.01% 3089
2023
Q3 		$20M Buy
3,668,200
+1,010,500
+38% +$8.1M ﹤0.01% 1858
2023
Q2 		$24.6M Sell
2,657,700
-1,145,100
-30% -$9.69M 0.01% 1679
2023
Q1 		$31.3M Buy
3,802,800
+1,127,600
+42% +$12.5M 0.01% 1495
2022
Q4 		$29.8M Buy
2,675,200
+1,558,400
+140% +$18.1M 0.01% 1563
2022
Q3 		$13.2M Buy
1,116,800
+463,500
+71% +$7.02M ﹤0.01% 2377
2022
Q2 		$9.98M Buy
653,300
+363,300
+125% +$6.54M ﹤0.01% 2694
2022
Q1 		$6.13M Sell
290,000
-8,500
-3% -$183K ﹤0.01% 3789
2021
Q4 		$7.05M Sell
298,500
-134,400
-31% -$2.88M ﹤0.01% 3705
2021
Q3 		$8.69M Buy
432,900
+263,300
+155% +$5.4M ﹤0.01% 3323
2021
Q2 		$3.41M Buy
169,600
+52,400
+45% +$1.12M ﹤0.01% 5296
2021
Q1 		$2.49M Sell
117,200
-69,600
-37% -$1.5M ﹤0.01% 5882
2020
Q4 		$4.07M Buy
186,800
+42,300
+29% +$824K ﹤0.01% 4026
2020
Q3 		$2.55M Sell
144,500
-108,000
-43% -$2.01M ﹤0.01% 4272
2020
Q2 		$4.75M Sell
252,500
-48,700
-16% -$862K ﹤0.01% 3162
2020
Q1 		$5.21M Buy
301,200
+167,800
+126% +$3.51M ﹤0.01% 2648
2019
Q4 		$2.82M Sell
133,400
-182,700
-58% -$3.7M ﹤0.01% 3876
2019
Q3 		$6.18M Buy
316,100
+228,200
+260% +$4.19M ﹤0.01% 2813
2019
Q2 		$1.53M Sell
87,900
-31,700
-27% -$571K ﹤0.01% 4979
2019
Q1 		$2.21M Buy
119,600
+12,300
+11% +$219K ﹤0.01% 4296
2018
Q4 		$1.73M Buy
107,300
+85,600
+394% +$1.35M ﹤0.01% 4384
2018
Q3 		$324K Sell
21,700
-15,400
-42% -$225K ﹤0.01% 7440
2018
Q2 		$521K Buy
+37,100
New +$491K ﹤0.01% 6291
2017
Q3 		– Sell
-23,000
Closed -$296K – 7837
2017
Q2 		$296K Sell
23,000
-14,800
-39% -$197K ﹤0.01% 5934
2017
Q1 		$487K Buy
37,800
+25,200
+200% +$322K ﹤0.01% 5068
2016
Q4 		$155K Sell
12,600
-30,600
-71% -$396K ﹤0.01% 6485
2016
Q3 		$638K Buy
43,200
+30,600
+243% +$463K ﹤0.01% 4482
2016
Q2 		$192K Sell
12,600
-1,100
-8% -$15.6K ﹤0.01% 5868
2016
Q1 		$178K Buy
13,700
+11,600
+552% +$132K ﹤0.01% 5719
2015
Q4 		$24K Sell
2,100
-3,500
-63% -$40K ﹤0.01% 7803
2015
Q3 		$62K Sell
5,600
-3,100
-36% -$38.5K ﹤0.01% 7421
2015
Q2 		$114K Sell
8,700
-66,600
-88% -$929K ﹤0.01% 6959
2015
Q1 		$1.11M Buy
+75,300
New +$1.12M ﹤0.01% 3791
2014
Q4 		– Sell
-1,900
Closed -$23K – 8640
2014
Q3 		$23K Buy
1,900
+600
+46% +$7.98K ﹤0.01% 7344
2014
Q2 		$17K Buy
+1,300
New +$17.3K ﹤0.01% 7393

Other funds holding MPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Citadel Advisors's MPT Position: Q1 2026 in Review

Citadel Advisors increased its Medical Properties Trust (MPT) stake by 472% in Q1 2026, buying an estimated $4.99M and bringing the position to 1,159,334 shares worth $5.37M. The position accounts for ﹤0.01% of the portfolio, ranked #4232.

Citadel Advisors first reported a position in MPT in Q2 2013 and has held it in 46 quarters since. The position peaked at $56.6M in Q3 2020. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Citadel Advisors held 1,159,334 shares of Medical Properties Trust worth $5.37M as of Q1 2026.
  • Citadel Advisors bought 956,724 Medical Properties Trust shares in Q1 2026, an estimated $4.99M.
  • Medical Properties Trust made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4232 holding.
  • Citadel Advisors first reported a position in Medical Properties Trust in Q2 2013 and has held it in 46 quarters since.
  • Citadel Advisors's Medical Properties Trust position peaked at $56.6M in Q3 2020.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.